| Health / Medical Topics |
Immunocytokine NHS-IL2-LT
A fusion protein consisting of a mouse-human chimeric antibody directed against DNA released by necrotic tumor cells fused to two molecules of a genetically modified human interleukin-2 (IL-2) with potential antineoplastic activity. Upon administration, the antibody moiety of immunocytokine NHS-IL2-LT binds to DNA released by necrotic tumor cells located primarily at the core of necrotic solid tumors, delivering the IL-2 moiety. In turn, the IL-2 moiety of this agent activates the immune system to mount a cytotoxic T lymphocyte response against nearby tumor cells. (NCI Thesaurus)
YOU MAY ALSO LIKE
A fusion protein consisting of the heavy-chains of the human antibody NHS76, raised against DNA released by necrotic tumor cells, and fused…
A laboratory tissue staining procedure involving monoclonal or polyclonal antibodies that react with specific tissue antigens. Initially used as a research…
A combination of 3 fluorescent-tagged monoclonal antibodies. Recently licensed for screening of bladder cancer recurrence by urine test.
A type of treatment that uses an immune substance, such as a monoclonal antibody, that is chemically linked to a cell-killing substance…
An immunoconjugate containing a glycoengineered, humanized monoclonal antibody directed against the human epidermal growth factor receptor HER3 (ErbB3), with potential antineoplastic…
An agent that consists of an immune substance, such as a monoclonal antibody, antigen or an immunoglobulin, and covalently bound to other…
